Development and use of human pancreatic cell lines
Patent Number: 6110743
Date of First Priority Issue: Friday February 10th, 1995
Date Issued: Tuesday August 29th, 2000
Assignee: The Regents of the University of California (Oakland, CA); Whittier Institute for Diabetes and Endocrinology (La Jolla, CA)
Inventors: Levine, Fred (Del Mar, CA); Wang, Sijian (Dallas, TX); Beattie, Gillian M. (Poway, CA); Hayek, Alberto (La Jolla, CA)
From Class: Use
Comments: No comments
This patent covers islet stem cells and cell lines that generate islet cells. This patent could be useful for the treatment of type 1 diabetes. In some cases, it may be beneficial to encapsulate the cell lines so as to avoid immune mediated rejection. Alternatively these cells would provide a great source of tissue for using the Edmonton Protocol.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.